{"id":"W2767911405","doi":"10.1155/2017/5264216","title":"Ustekinumab and Vedolizumab Dual Biologic Therapy in the Treatment of Crohn’s Disease","year":2017,"lang":"en","type":"article","venue":"Case Reports in Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Saskatchewan","funders":"","keywords":"Vedolizumab; Ustekinumab; Medicine; Refractory (planetary science); Crohn's disease; Internal medicine; Maintenance therapy; Disease; Gastroenterology; Adalimumab; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003889778,0.0004407136,0.0006618444,0.0007728063,0.000850832,0.000778363,0.0003855419,0.002477807,0.001168792],"category_scores_gemma":[0.001026351,0.0002972038,0.0006135424,0.0004321371,0.0008094418,0.0006384553,0.0005221546,0.001150026,0.0003002039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003913325,"about_ca_system_score_gemma":0.0003036964,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004637623,"about_ca_topic_score_gemma":0.0006802286,"domain_scores_codex":[0.9995496,0.0001265878,0.00007096626,0.00005554514,0.00006522702,0.0001320898],"domain_scores_gemma":[0.9994879,0.0002135484,0.0001291041,0.00002329691,0.00001683161,0.0001293111],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.0004418817,0.00014633,0.01660277,0.0002080608,0.00004875488,0.9496104,0.0004453154,0.0001495415,0.008098002,0.0007440926,0.0006963752,0.02280842],"study_design_scores_gemma":[0.00005805031,0.0001766357,0.005318377,0.00004348833,0.00005089457,0.987601,0.0001849595,0.0003446331,0.001565961,0.0002028918,0.004444268,0.000008733431],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9065225,0.07694576,0.001699019,0.003359974,0.0002444662,0.0000428545,0.00002854317,0.00006479605,0.01109219],"genre_scores_gemma":[0.9883478,0.007977828,0.00100096,0.0006752835,0.0004687003,0.00001529428,0.00002414656,0.000007206545,0.001482765],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002477807,"threshold_uncertainty_score":0.003910005,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02769528129728425,"score_gpt":0.312810326434479,"score_spread":0.2851150451371947,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}